<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>Stockwatch - Key Events</title>
    <link>https://www.stockwatch.live/</link>
    <description>Real-time corporate announcements, deals, and financial results.</description>
    <lastBuildDate>Sun, 15 Feb 2026 06:45:31 +0000</lastBuildDate>
    <language>en-in</language>
    <atom:link href="https://api.stockwatch.live/api/keyEvents" rel="self" type="application/rss+xml" />
    
    <item>
      <title>[LGT] LGT Business Connextions Ltd: Monitoring Agency Report Confirms Appropriate Utilization of Public Issue Proceeds</title>
      <link>https://www.stockwatch.live/news?showModal=true&name=LGT+Business+Connextions+Ltd&title=LGT+Business+Connextions+Ltd%3A+Monitoring+Agency+Report+Confirms+Appropriate+Utilization+of+Public+Issue+Proceeds&newsId=1e9ffb53-e1d2-4502-804f-a492e05ea1a7&token=MWU5ZmZiNTMtZTFk</link>
      <guid isPermaLink="false">1e9ffb53-e1d2-4502-804f-a492e05ea1a7</guid>
      <pubDate>Sun, 15 Feb 2026 06:30:59 +0000</pubDate>
      <category>Quarterly Result</category>
      <description><![CDATA[<p>The Monitoring Agency Report for the quarter ended December 31, 2025 for LGT Business Connextions Limited, issued by Infomerics Ratings Limited, confirms the appropriate utilization of proceeds from the public issue. The report was submitted in accordance with Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Regulation 162A of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The proceeds from the public issue have been utilized for the objects mentioned in the offer document. The report also declares that there is no deviation from the objects and the range of deviation is nil.</p><ul><li>Monitoring Agency Report confirms appropriate utilization of public issue proceeds</li><li>Report submitted in accordance with SEBI regulations</li><li>No deviation from the objects, range of deviation is nil</li><li>Infomerics Ratings Limited is the Monitoring Agency</li><li>Report issued for the quarter ended December 31, 2025</li></ul><p>ðŸ“„ <a href="https://www.bseindia.com/xml-data/corpfiling/AttachLive/331b53f4-c809-4e3b-add6-a5a98d5ede08.pdf">Read Official Filing (PDF)</a></p><br/><small>Company: LGT Business Connextions Ltd | Category: Quarterly Result</small>]]></description>
    </item>
    <item>
      <title>[DIACABS] Diamond Power Infrastructure Limited Reports Q3 and Nine Months FY26 Financial Results</title>
      <link>https://www.stockwatch.live/news?showModal=true&name=Diamond+Power+Infrastructure+Limited-%24&title=Diamond+Power+Infrastructure+Limited+Reports+Q3+and+Nine+Months+FY26+Financial+Results&newsId=55ac1224-69ce-435d-9885-24c6c3dce4a1&token=NTVhYzEyMjQtNjlj</link>
      <guid isPermaLink="false">55ac1224-69ce-435d-9885-24c6c3dce4a1</guid>
      <pubDate>Sun, 15 Feb 2026 05:31:05 +0000</pubDate>
      <category>Quarterly Result</category>
      <description><![CDATA[<p>Diamond Power Infrastructure Limited has shared the investor updates for the quarter and nine months ended December 31, 2025. The updates will be discussed in upcoming investor calls and provide insights into the company&apos;s performance. The financial results and investor presentation are available on the company&apos;s website.</p><ul><li>Revenue for the nine months ended December 31, 2025, stood at â‚¹ 474.08 cr</li><li>The company has order position of â‚¹ 3300 cr+ as of December 31, 2025</li><li>Diamond Power Infrastructure Limited has a strong approval order position and recognition with 275 customers in leading labs accredited with NABL 1322</li><li>Key approvals and orders contribute to the company&apos;s growth</li><li>The company&apos;s progress and performance are highlighted in the investor presentation for Q3 FY 2025-26</li></ul><p>ðŸ“„ <a href="https://www.bseindia.com/xml-data/corpfiling/AttachLive/fc54064a-b8a3-4187-9f3c-c9448db348ad.pdf">Read Official Filing (PDF)</a></p><br/><small>Company: Diamond Power Infrastructure Limited-$ | Category: Quarterly Result</small>]]></description>
    </item>
    <item>
      <title>[MANSIFIN] Mansi Finance (Chennai) Ltd Reports Q3 Results with 12.82% YoY Growth in Total Comprehensive Income</title>
      <link>https://www.stockwatch.live/news?showModal=true&name=MANSI+FINANCE+%28CHENNAI%29+LTD.&title=Mansi+Finance+%28Chennai%29+Ltd+Reports+Q3+Results+with+12.82%25+YoY+Growth+in+Total+Comprehensive+Income&newsId=6d0e7350-3c57-4ef5-be88-9df0adfcf12f&token=NmQwZTczNTAtM2M1</link>
      <guid isPermaLink="false">6d0e7350-3c57-4ef5-be88-9df0adfcf12f</guid>
      <pubDate>Sun, 15 Feb 2026 04:01:55 +0000</pubDate>
      <category>Quarterly Result</category>
      <description><![CDATA[<strong>ðŸ”¥ Trending</strong><br/><p>Mansi Finance (Chennai) Ltd, a leading financial company, has announced its financial results for the quarter ended December 31, 2025. The company reported a total comprehensive income of INR 830.46 crores, representing a 12.82% year-over-year growth. The revenue from operations stood at INR 209.02 crores, while the profit before tax was INR 104.74 crores. The company&apos;s total expenses were INR 113.30 crores, and the earnings per equity share were INR 106.70. The financial results have been approved by the Board of Directors and reviewed by the Audit Committee.</p><ul><li>Total comprehensive income grew by 12.82% YoY</li><li>Revenue from operations stood at INR 209.02 crores</li><li>Profit before tax was INR 104.74 crores</li><li>Total expenses were INR 113.30 crores</li><li>Earnings per equity share were INR 106.70</li></ul><p>ðŸ“„ <a href="https://www.bseindia.com/xml-data/corpfiling/AttachLive/9e25be66-82cc-432f-aa52-fd6fbaba45a6.pdf">Read Official Filing (PDF)</a></p><br/><small>Company: MANSI FINANCE (CHENNAI) LTD. | Category: Quarterly Result</small>]]></description>
    </item>
    <item>
      <title>[EVERESTO] Everest Organics Ltd Submits Unaudited Financial Results for Q3 &amp; Nine Months Ended Dec 31, 2025</title>
      <link>https://www.stockwatch.live/news?showModal=true&name=EVEREST+ORGANICS+LTD.&title=Everest+Organics+Ltd+Submits+Unaudited+Financial+Results+for+Q3+%26+Nine+Months+Ended+Dec+31%2C+2025&newsId=3623f418-5764-444b-a864-621bdc6777e1&token=MzYyM2Y0MTgtNTc2</link>
      <guid isPermaLink="false">3623f418-5764-444b-a864-621bdc6777e1</guid>
      <pubDate>Sun, 15 Feb 2026 00:07:12 +0000</pubDate>
      <category>Quarterly Result</category>
      <description><![CDATA[<p>Everest Organics Limited has submitted its unaudited financial results for the quarter and nine months ended December 31, 2025. The company reported a sales turnover of Rs 5026.85 Lakhs for the quarter, with domestic sales at Rs. 3970.75 Lakhs and export sales at Rs. 1056.10 Lakhs. The company operates in one reportable business segment: Active Pharmaceutical Ingredients (APIs) and Intermediates. There were 2,63,157 Equity Share Warrants outstanding on 31.12.2025. The financial results were reviewed and recommended by the Audit Committee and approved by the Board of Directors.</p><ul><li>Sales turnover of Rs 5026.85 Lakhs for the quarter</li><li>Domestic sales of Rs. 3970.75 Lakhs and export sales of Rs. 1056.10 Lakhs</li><li>Operates in the Active Pharmaceutical Ingredients (APIs) and Intermediates segment</li><li>2,63,157 Equity Share Warrants outstanding on 31.12.2025</li><li>Financial results reviewed and approved by the Audit Committee and Board of Directors</li></ul><p>ðŸ“„ <a href="https://www.bseindia.com/xml-data/corpfiling/AttachLive/ad154429-25ae-4fcd-8e5b-34284c38769b.pdf">Read Official Filing (PDF)</a></p><br/><small>Company: EVEREST ORGANICS LTD. | Category: Quarterly Result</small>]]></description>
    </item>
    <item>
      <title>[GKSL] Gujarat Kidney and Super Speciality Ltd Confirms No Deviations in Fund Utilization as of December 31, 2025</title>
      <link>https://www.stockwatch.live/news?showModal=true&name=Gujarat+Kidney+and+Super+Speciality+Ltd&title=Gujarat+Kidney+and+Super+Speciality+Ltd+Confirms+No+Deviations+in+Fund+Utilization+as+of+December+31%2C+2025&newsId=65bd83b8-ba8d-422e-aec8-dee45dbca5db&token=NjViZDgzYjgtYmE4</link>
      <guid isPermaLink="false">65bd83b8-ba8d-422e-aec8-dee45dbca5db</guid>
      <pubDate>Sun, 15 Feb 2026 00:03:48 +0000</pubDate>
      <category>Quarterly Result</category>
      <description><![CDATA[<p>Gujarat Kidney and Super Speciality Ltd, previously known as Gujarat Kidney and Super Speciality Private Limited, has released a statement of deviation and variation for the third quarter ended on December 31, 2025. The statement confirms that there were no deviations or variations in the use of proceeds of the public issue. The company has utilized funds for various purposes including proposed acquisitions, part payment of purchase consideration for acquired hospitals, acquisitions of additional shareholding in subsidiaries, funding capital expenditure, buying robotics equipment, and funding inorganic growth. The company has also made partial repayment and prepayment of certain outstanding secured borrowings.</p><ul><li>Gujarat Kidney and Super Speciality Ltd confirms no deviations in fund utilization</li><li>Funds utilized for proposed acquisitions, part payment of purchase consideration, and acquisitions of additional shareholding</li><li>Funding provided for capital expenditure, buying robotics equipment, and inorganic growth</li><li>Partial repayment and prepayment of certain outstanding secured borrowings</li><li>Statement released as per Regulation 32 of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015</li></ul><p>ðŸ“„ <a href="https://www.bseindia.com/xml-data/corpfiling/AttachLive/723e78e5-419d-42df-9c9d-60e85533b325.pdf">Read Official Filing (PDF)</a></p><br/><small>Company: Gujarat Kidney and Super Speciality Ltd | Category: Quarterly Result</small>]]></description>
    </item>
    <item>
      <title>[KMFBLDR] KMF Builders &amp; Developers Ltd. Announces Q3 and Nine Months Unaudited Financial Results for the Period Ending 31st December, 2025</title>
      <link>https://www.stockwatch.live/news?showModal=true&name=KMF+BUILDERS+%26+DEVELOPERS+LTD.&title=KMF+Builders+%26+Developers+Ltd.+Announces+Q3+and+Nine+Months+Unaudited+Financial+Results+for+the+Period+Ending+31st+December%2C+2025&newsId=dffb94e3-b3c5-41dc-b91a-86269ee91d4a&token=ZGZmYjk0ZTMtYjNj</link>
      <guid isPermaLink="false">dffb94e3-b3c5-41dc-b91a-86269ee91d4a</guid>
      <pubDate>Sun, 15 Feb 2026 00:03:23 +0000</pubDate>
      <category>Quarterly Result</category>
      <description><![CDATA[<p>KMF Builders &amp; Developers Ltd. has announced its unaudited financial results for the quarter and nine months ended 31st December, 2025. The company&apos;s revenue from operations and other income have been reported. The financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) and other applicable accounting principles. The company&apos;s management acknowledges the lack of ongoing projects, resulting in a loss with no revenue except interest income.</p><ul><li>Unaudited financial results for the quarter and nine months ended 31st December, 2025</li><li>Revenue from operations and other income reported</li><li>Financial results prepared in accordance with Ind AS and other accounting principles</li><li>Company acknowledges loss with no revenue except interest income</li><li>Reviewed by the audit committee and approved by the board of Directors</li></ul><p>ðŸ“„ <a href="https://www.bseindia.com/xml-data/corpfiling/AttachLive/8bcf68bc-8df3-446b-83b9-fd852a967ac4.pdf">Read Official Filing (PDF)</a></p><br/><small>Company: KMF BUILDERS & DEVELOPERS LTD. | Category: Quarterly Result</small>]]></description>
    </item>
    <item>
      <title>[VISVEN] Vishvprabha Ventures Ltd. Announces Q3 Results with Net Profit of â‚¹ 58.83 Crores</title>
      <link>https://www.stockwatch.live/news?showModal=true&name=Vishvprabha+Ventures+Ltd&title=Vishvprabha+Ventures+Ltd.+Announces+Q3+Results+with+Net+Profit+of+%E2%82%B9+58.83+Crores&newsId=f37792bd-dcb3-4878-895f-38e288ff74e8&token=ZjM3NzkyYmQtZGNi</link>
      <guid isPermaLink="false">f37792bd-dcb3-4878-895f-38e288ff74e8</guid>
      <pubDate>Sun, 15 Feb 2026 00:02:50 +0000</pubDate>
      <category>Quarterly Result</category>
      <description><![CDATA[<p>Vishvprabha Ventures Ltd. has announced its unaudited financial results for the quarter ended December 31, 2025. The company&apos;s total income from operations stands at â‚¹ 762.17 Crores, with a net profit of â‚¹ 58.83 Crores. The results were reviewed by the Audit Committee and approved by the Board of Directors.</p><ul><li>Total income from operations: â‚¹ 762.17 Crores</li><li>Net profit: â‚¹ 58.83 Crores</li><li>Reviewed by the Audit Committee</li><li>Approved by the Board of Directors</li></ul><p>ðŸ“„ <a href="https://www.bseindia.com/xml-data/corpfiling/AttachLive/de3f6ab0-faff-41c3-9d6c-58b8672264dd.pdf">Read Official Filing (PDF)</a></p><br/><small>Company: Vishvprabha Ventures Ltd | Category: Quarterly Result</small>]]></description>
    </item>
    <item>
      <title>[EVERESTO] Everest Organics Q3 &amp; YTD 2025 Financial Results Submitted, With Unaudited Financial Results &amp; Limited Review Report</title>
      <link>https://www.stockwatch.live/news?showModal=true&name=EVEREST+ORGANICS+LTD.&title=Everest+Organics+Q3+%26+YTD+2025+Financial+Results+Submitted%2C+With+Unaudited+Financial+Results+%26+Limited+Review+Report&newsId=9a9b45ae-f4bc-484e-b9a4-a2bc43533473&token=OWE5YjQ1YWUtZjRi</link>
      <guid isPermaLink="false">9a9b45ae-f4bc-484e-b9a4-a2bc43533473</guid>
      <pubDate>Sun, 15 Feb 2026 00:02:30 +0000</pubDate>
      <category>Quarterly Result</category>
      <description><![CDATA[<p>Everest Organics Limited has submitted its unaudited financial results for the quarter and nine months ended December 31, 2025. The company&apos;s revenue for Q3 2025 was Rs. 5026.85 Lakhs, with domestic sales of Rs. 3970.75 Lakhs and export sales of Rs. 1056.10 Lakhs. The company operates in the Active Pharmaceutical Ingredients (API) business segment. There are 2,63,157 Equity Share Warrantis outstanding, and 1,60,322 equity shares are still in the Unclaimed Suspense Account as of December 31, 2025. The company is undergoing a review by the Audit Committee and the Board of Directors. The company&apos;s financial results were prepared in accordance with Ind AS and other accounting principles generally accepted in India.</p><ul><li>Everest Organics Limited submitted unaudited financial results for Q3 and YTD 2025.</li><li>Revenue for Q3 2025 was Rs. 5026.85 Lakhs with domestic and export sales.</li><li>The company operates in the Active Pharmaceutical Ingredients (API) business segment.</li><li>There are 2,63,157 Equity Share Warrantis outstanding and 1,60,322 equity shares in the Unclaimed Suspense Account.</li><li>The company&apos;s financial results were prepared in accordance with Ind AS and other accounting principles generally accepted in India.</li></ul><p>ðŸ“„ <a href="https://www.bseindia.com/xml-data/corpfiling/AttachLive/6eb0b160-91b7-4276-a260-6aa17c487009.pdf">Read Official Filing (PDF)</a></p><br/><small>Company: EVEREST ORGANICS LTD. | Category: Quarterly Result</small>]]></description>
    </item>
    <item>
      <title>[ANURAS] Anupam Rasayan India Ltd Executes Agreements and Corporate Guarantee for Overseas Investments and Credit Facilities</title>
      <link>https://www.stockwatch.live/news?showModal=true&name=Anupam+Rasayan+India+Ltd&title=Anupam+Rasayan+India+Ltd+Executes+Agreements+and+Corporate+Guarantee+for+Overseas+Investments+and+Credit+Facilities&newsId=c0608b86-e14d-4186-a805-e2ed52ca9c3d&token=YzA2MDhiODYtZTE0</link>
      <guid isPermaLink="false">c0608b86-e14d-4186-a805-e2ed52ca9c3d</guid>
      <pubDate>Sun, 15 Feb 2026 00:02:28 +0000</pubDate>
      <category>Investment</category>
      <description><![CDATA[<p>Anupam Rasayan India Limited has informed about the execution of agreements and corporate guarantee in accordance with the Listing Regulations, 2015. The company acquired 100% equity stake in Doriath S.a r.1. and 15% equity stake in Batam S.a r.l. through overseas investments. A credit facility of USD 20,000,000 has been availed by Doriath, and a credit facility of USD 30,000,000 has been availed by the company as External Commercial Borrowing. Additionally, various agreements such as note subscription agreements, facility agreements, security agent agreements, security trustee agreements, corporate guarantee deeds, deeds of hypothecation, mortgage documents, pledge agreements, non-disposal undertaking, loan agreement, and share subscription agreement have been executed.</p><ul><li>Execution of agreements and corporate guarantee for overseas investments and credit facilities.</li><li>Acquisition of 100% equity stake in Doriath S.a r.1. and 15% equity stake in Batam S.a r.l.</li><li>Availing of credit facilities worth USD 20,000,000 by Doriath and USD 30,000,000 by the company as External Commercial Borrowing.</li><li>Execution of various agreements such as note subscription agreements, facility agreements, security agent agreements, security trustee agreements, corporate guarantee deeds, deeds of hypothecation, mortgage documents, pledge agreements, non-disposal undertaking, loan agreement, and share subscription agreement.</li></ul><p>ðŸ“„ <a href="https://www.bseindia.com/xml-data/corpfiling/AttachLive/17627797-0e47-418b-b729-d133133a49de.pdf">Read Official Filing (PDF)</a></p><br/><small>Company: Anupam Rasayan India Ltd | Category: Investment</small>]]></description>
    </item>
    <item>
      <title>[SSMD] SSMD Agrotech India Ltd. Appoints Ms. Nancy Jain as Internal Auditor, Authorizes MD for MOU and OD Facility</title>
      <link>https://www.stockwatch.live/news?showModal=true&name=SSMD+Agrotech+India+Ltd&title=SSMD+Agrotech+India+Ltd.+Appoints+Ms.+Nancy+Jain+as+Internal+Auditor%2C+Authorizes+MD+for+MOU+and+OD+Facility&newsId=8b6132a1-67b6-4053-aa64-322ea70ac86b&token=OGI2MTMyYTEtNjdi</link>
      <guid isPermaLink="false">8b6132a1-67b6-4053-aa64-322ea70ac86b</guid>
      <pubDate>Sun, 15 Feb 2026 00:01:47 +0000</pubDate>
      <category>Board Meeting</category>
      <description><![CDATA[<p>SSMD Agrotech India Ltd. has made several significant decisions during its Board meeting on 14th February 2026. The company accepted the resignation of Mr. Rajmani Thakur as Internal Auditor and appointed Ms. Nancy Jain as the new Internal Auditor for the Financial Year 2025-26. The Board also authorized Mr. Ishu Munjal, Managing Director, to negotiate, finalize, sign, and execute the Memorandum of Understanding (MOU) with DEMETER COMMODITIES SL for expansion of business in the Oil Sector. Furthermore, the Board approved the proposal for availing an Overdraft (OD) Facility up to Â¥5 Crore from a Bank and/or Financial Institution for the same purpose. The Board also adopted the Monitoring Agency Report for the quarter ended 31st December 2025.</p><ul><li>Resignation of Mr. Rajmani Thakur as Internal Auditor</li><li>Appointment of Ms. Nancy Jain as the new Internal Auditor</li><li>Authorization of Managing Director for MOU execution with DEMETER COMMODITIES SL</li><li>Approval for Overdraft (OD) Facility up to Â¥5 Crore</li><li>Adoption of Monitoring Agency Report for Q4 2025</li></ul><p>ðŸ“„ <a href="https://www.bseindia.com/xml-data/corpfiling/AttachLive/b68942a7-cd3a-4342-8fd9-c7c0e2855e94.pdf">Read Official Filing (PDF)</a></p><br/><small>Company: SSMD Agrotech India Ltd | Category: Board Meeting</small>]]></description>
    </item>
  </channel>
</rss>